Ildong Pharmaceutical begins restructuring… Executive level ERP operation

2023-05-23 10:48:45 Ildong Holdings and Ildong Pharmaceuticals will start a business renewal. This is a view of the Ildong Pharmaceutical office building. On the 23rd, Ildong Pharmaceutical Group announced to internal members a plan for reform, including efficiency in research costs, promotion of early license out (L/O) of pipelines, item restructuring, and employee ERP. This … Read more

FDA Approval

2023-05-15 02:47:03 Astellas Pharmaceuticals’ menopausal symptom treatment Veoza (Fezolinetant) was able to launch in the US market after an extension of the review period. Astellas Veoja product photo The U.S. Food and Drug Administration (FDA) announced on the 12th (local time) that Astellas Pharmaceuticals has approved Veozah, a new drug for the treatment of hot … Read more

Emphasis on IQVIA Bio Korea’s surprise booth as a biopharmaceutical partner

2023-05-12 22:10:11 “I came out to raise IQVIA’s awareness and publicize its role as a partner at a time when Korea’s biopharmaceutical industry is growing.” IQVIA Korea, a company specializing in clinical development and data, participated in BIOKOREA 2023 for the first time this year and is actively communicating with the domestic pharmaceutical bio industry. … Read more

Genome & Company appoints Hong Yoo-seok, former CEO of GSK

2023-05-08 10:06:32 Hong Yoo-seok, new general manager of Genome & Company Genome & Company, a microbiome-based new drug development company, announced on the 8th that it had appointed Yoo-seok Hong as its general representative. Genome & Company plans to go through the process of appointing Hong Yoo-seok as the new CEO through the regular shareholders’ … Read more

AstraZeneca Korea appoints executive director Lim Jae-yoon as head of the medical department

2023-05-04 02:47:52 AstraZeneca Korea Department of Medicine Jaeyoon Lim Executive Director AstraZeneca Korea announced on the 4th that it had appointed Lim Jae-yoon (Country Medical Director) to oversee the medical department. Lim Jae-yoon, Executive Director of AstraZeneca Korea Medical Department, joined AstraZeneca Korea Medical Department as Oncology therapeutic area Lead in 2019 and contributed to … Read more

“Saw Palmetto Extract and Benign Prostatic Hyperplasia Treatment: Exploring Over-The-Counter Medicines, Health Functional Foods, and Clinical Options”

2023-05-01 20:30:00 Amid the recent trend of increasing patients with benign prostatic hyperplasia due to the aging population, the related treatment market is also excited. Among them, ‘Saw Palmetto Extract (Serenoa repens)’ is attracting attention again. In the clinical field, it has already been recognized for its therapeutic effect in Europe, etc. According to the … Read more